Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis

• Prif Awduron: Nabila Ferahta (Awdur), Lukshe Kanagaratnam (Awdur), Moustapha Dramé (Awdur), Thomas Vogel (Awdur), Pierre-Jacques Ambrosi (Awdur), Pierre-Olivier Lang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2017-07-10.
• Pynciau: Research Article
• Mynediad Ar-lein: Connect to this object online.

<p><strong>Background: </strong>Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefi t is similar at the current recommended doses.</p&...